BRIEF INTERVENTIONS IN THE TREATMENT OF ALCOHOL USE - PDF Document

Presentation Transcript

  1. BRIEF INTERVENTIONS IN THE TREATMENT OF ALCOHOL USE DISORDERS IN RELEVANT SETTINGS Managing risky drinking in primary health care, emergency care, workplace and social service settings ABOUT BISTAIRS lar diseases, gastrointestinal diseases, mental and behav- ioural disorders, and communicable diseases. These outcomes affect people’s health, well-being and ill- health, accidents and violence, diminished educational achievement, impaired performance and productivity at work and have an effect of crime and impaired family functioning. The EU project BISTAIRS (Brief interventions in the treatment of alcohol use disorders in relevant settings) aims to evaluate the implementation of tailored brief intervention (BI) toolkits for risky drinking in primary health care, emergency care, workplace and social ser- vices settings across the EU. ASSOCIATED PARTNERS For most alcohol-related health conditions, risk increases with the amount of alcohol drunk both regularly and on any one occasion. In 2009, average adult consumption amongst drinkers in Europe was 30 g alcohol per day (Rehm et al. 2012). One in eight adults drank at least 60 g, on any occasion several times a week, with nearly five per cent of men, but only 1 in 1,000 women doing this every day (Shield et al. 2012). Coordination Centre for Interdisciplinary Addiction Research (CIAR) University of Hamburg Prof. Dr. Jens Reimer, MBA Risky drinking is a casual factor in injuries, it inevitable impacts the work of accident and emergency depart- ments. It is a contributory factor in absenteeism and presenteeism, it inevitably impacts employers. SCREENING AND BRIEF INTERVENTION (SBI) Partner Function Work package leader; University of Hamburg (CIAR) National field test coordinator Hamburg, Germany University of Newcastle upon Tyne (UNEW) Work package leader Brief interventions (BI) for alcohol have been shown to be effective in the management of alcohol consumption for non treatment-seeking harmful alcohol drinkers. Most evidence of BI effectiveness has been gathered in primary health care settings. As concluded in the UK NICE guidelines, the overall evidence of BI effectiveness strongly suggests an extension of BI implementation in settings beyond primary health care, such as in work- place health services, emergency care and social ser- vices. Newcastle, United Kingdom Fundacio Clinic per al la Recera Biomedica (FCRB) Work package leader Barcelona, Spain (Catalonia) Work package leader; Instituto Superiore Di Santa (ISS) National field test coordinator Rome, Italy Generalität de Catalunya (GEN- CAT) National field test coordinator “Screening is a systematic process of identifying people whose alcohol consumption places them at increased risk of physical, psychological or social problems and who would benefit from a preventative intervention” (NICE) 2010). Barcelona, Spain (Catalonia) National Institute of Public Health (NIPH) National field test coordinator Prague, Czech Republic Institute on Drugs and Drug Addic- tion (IDT) Brief intervention is a discussion aimed at raising an individual's awareness of their risky behavior and motivating them to change it. National field test coordinator Lisbon, Portugal RISKY DRINKING AND HEALTH IMPACTS It has been estimated that about only 1 in 20 of those with risky drinking are actually identified and offered brief advice by a primary health care provider (WHO Alcohol is a causal factor in over 200 different medical diseases and conditions, including cancers, cardiovascu-

  2. BRIEF INTERVENTIONS IN THE TREATMENT OF ALCOHOL USE DISORDERS IN RELEVANT SETTINGS Managing risky drinking in primary health care, emergency care, workplace and social service settings 2009; Wolstenholme et al 2012). For those people, drinking is affecting their own health and well-being and that of those around them, including family and friends, SBI could be effective in helping reducing the levels of risky drinking. BI is not complicated, builds on the skills many accident and emergency doctors al- ready have, and can be delivered in five to ten minutes. GENERAL OBJECTIVES TARGET GROUP Intermediate target groups • target group specific, field-tested BI toolkits & guidelines for their implementation • Policy makers • Associations • Professionals • Harmful alcohol drinkers BISTAIRS Target groups BISTAIRS aims • • to foster BI implementation in relevant settings to provide a substantial contribution to the EU strategy to reduce alcohol related harm to increase the impact of secondary alcohol pre- vention in the EU to contribute to a reduction of the negative social consequences of harmful alcohol consumption in the EU to decrease the EU wide identified attributable health risks to contribute to the reduction of the tangible costs of alcohol related harm METHOD AND MEANS • • Identifying the implementation status of • BI in the EU by sending a questionnaire to members of the respective networks • • Tailoring BI toolkits, evaluating in field tests •  four field tests will be conducted in 5 coun- tries (three of them with lower experience in the implementation of BI) •  Using focus groups for field-test evaluation • Conducting a scientific board meeting for guideline preparation SPECIFIC OBJECTIVES Good practice of BI Identification & assessment of BI in different settings  decision-making purposes, applying ade- quate methodologies for consensus finding Development & field test of BI toolkits Tailored BI packages (tools, methods, materials) for each setting will be field tested in five EU member states Phase I Guidelines for tailored BI approaches Guidelines for the development of BI approaches for different settings and their widespread implementation in the EU Secondary analyses & identification of good practise Phase II Scientific board meeting I & field tests Dissemination of toolkits & guidelines Dissemination of set of tailored toolkits, guidelines, training manuals and further documents in order to initiate a widespread implementation of adapted BI ap- proaches in the EU Phase II Guideline preparation & scientific board meeting II Phase IV Dissemination